AMBEY2025-04-012025-06-30AMBEY2025-06-30AMBEY2025-03-31AMBEY2025-06-30ImpositionOfFineOrPenaltyDomain1xbrli:pureAMBEYNOTLISTEDINE0M3I01029Ambey Laboratories Limited2025-04-012026-03-31Quarterly2025-06-30SMEfalsePursuant to Regulation 15(2) of SEBI ((Listing Obligation and Disclosure Requirements) Regulations, 2015 the compliance with Corporate Governance provisions as specified in Regulations 17, 17 A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26, 26A, 27 and clauses (b) to (i) and (t) of sub-regulation (2) of Regulation 46 and Para C, D and E of Schedule V are not applicable on the listed entity which has listed its specified securities on the SME Exchange. Since our Company is listed on SME Exchange, provisions of Regulation 27(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Disclosure under Annexure I (Part A) of SEBI Circular dated December 31, 2024 is not applicable on the Company for the quarter ended onJune 30,2025truefalseDuring the year ending 31st March, 2025, there were no acquisition of shares or voting rights in unlisted companiestruefalseThere are no ongoing tax litigations or disputes in terms of sub-para 8 of para B of Part A of Schedule IIItruecoma01243Original00000National Stock Exchange of India LimitedWarning Letter2025-04-08The violation pertains to the inadvertent disclosure of the Chief Executive Officer’s PAN in a stock exchange filing dated February 06, 2025, contrary to exchange guidelines prohibiting such disclosures.NA